Other points to discuss are the serum levels of β-NGF, CXCL1, CXCL12, HGF, IFN-α, IL-16, IL-18, IL-2R, Leptin and sIL-6Ra found for the T2D-HCC patients. This evidence concerns the gene IL18 and hepatocellular carcinoma.